Floatz logo

Therapeutic Asset Ratings

2,003 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Beta-Thalassemia Major
M.D. Anderson Cancer CenterP1/2CCC (54)
Mesna
T-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer CenterP1/2CCC (54)
PEGFILGRASTIM
Acute Myeloid Leukemia
M.D. Anderson Cancer CenterP2/3CCC (54)
Abemaciclib
Female Reproductive Organ Cancer
M.D. Anderson Cancer CenterP2CCC (53)
Abiraterone Acetate
PSA Progression
M.D. Anderson Cancer CenterP2CCC (53)
Acalabrutinib
CCND1 Protein Overexpression
M.D. Anderson Cancer CenterP2CCC (53)
Acalabrutinib
CD20 Positive
M.D. Anderson Cancer CenterP2CCC (53)
Acalabrutinib
CD5 Positive
M.D. Anderson Cancer CenterP2CCC (53)
Acalabrutinib
FCER2 Negative
M.D. Anderson Cancer CenterP2CCC (53)
Acalabrutinib
t(11;14)(q13;q32)
M.D. Anderson Cancer CenterP2CCC (53)
Acetylsalicylic Acid
T Cells
M.D. Anderson Cancer CenterP2CCC (53)
Adebrelimab
Adjuvant Chemotherapy
M.D. Anderson Cancer CenterP2CCC (53)
Adebrelimab
ctDNA
M.D. Anderson Cancer CenterP2CCC (53)
Adebrelimab
Fruquintinib
M.D. Anderson Cancer CenterP2CCC (53)
Adebrelimab
Tislelizumab
M.D. Anderson Cancer CenterP2CCC (53)
Allogeneic Cytomegalovirus-Specific Cytotoxic T Lymphocytes
Cytomegalovirus Infection
M.D. Anderson Cancer CenterP2CCC (53)
Allogeneic Cytomegalovirus-Specific Cytotoxic T Lymphocytes
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Allogeneic Cytomegalovirus-Specific Cytotoxic T Lymphocytes
Cancer
M.D. Anderson Cancer CenterP2CCC (53)
Anamorelin
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Anamorelin
Cancer Fatigue
M.D. Anderson Cancer CenterP2CCC (53)
Anamorelin
Recurrent Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Anti-Thymoglobulin, Rabbit
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
M.D. Anderson Cancer CenterP2CCC (53)
Anti-Thymoglobulin, Rabbit
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
M.D. Anderson Cancer CenterP2CCC (53)
Asciminib
Malignant Solid Tumors
M.D. Anderson Cancer CenterP2CCC (53)
Atezolizumab
Appendix Adenocarcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Showing 526 to 550 of 2,003 assets
PreviousPage 22 of 81Next